The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Aromatase inhibitor musculoskeletal toxicity (AIMT) in patients (pts) with early breast cancer (EBC): Prevalence, management, and association with non-adherence to AI.
 
Pietro Lapidari
Travel, Accommodations, Expenses - Lilly
 
Maryam B. Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Novartis; Osmol Therapeutics; Pfizer; Seagen
Speakers' Bureau - Lilly
Other Relationship - Cynosure/Hologic
 
Julie Havas
No Relationships to Disclose
 
Martina Pagliuca
Travel, Accommodations, Expenses - Gilead Sciences
 
Maria Alice B Franzoi
Speakers' Bureau - Novartis (Inst)
Research Funding - Resilience Care (Inst); Resilience Care (Inst)
 
Gwenn Menvielle
No Relationships to Disclose
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; PIERRE FABRE; Puma Biotechnology
Research Funding - AstraZeneca (Inst); DAIICHI-SANKYO (Inst); Gilead Sciences (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
Christelle Jouannaud
Honoraria - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Pfizer
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - MSD Oncology; Viatris
 
Baptiste Sauterey
No Relationships to Disclose
 
Olivier Tredan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe; Gilead Sciences; Lilly; MSD Oncology; Pfizer; Pierre Fabre; Roche; Sandoz-Novartis; Stemline Therapeutics; Veracyte
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche
 
Paul H. Cottu
Honoraria - AstraZeneca; Daiich Sankyo; Gilead Sciences; Gilead Sciences; Gilead Sciences; Lilly; NanoString Technologies (Inst); Novartis (Inst); Pfizer; Roche
Consulting or Advisory Role - Lilly; Pfizer
Research Funding - pfizer (Inst)
Travel, Accommodations, Expenses - Lilly; pfizer; Roche
 
Christelle Levy
Consulting or Advisory Role - Gilead Sciences; Lilly; Seagen
Travel, Accommodations, Expenses - Gilead Sciences; Pfizer
 
Florence Lerebours
Consulting or Advisory Role - AstraZeneca; Eisai; Gilead Sciences; Lilly; Menarini; Novartis; Roche; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
 
Sibille Everhard
No Relationships to Disclose
 
Anne-Laure Martin
No Relationships to Disclose
 
Ines Maria Vaz Duarte Luis
Honoraria - AstraZeneca (Inst); Novartis (Inst); Sandoz
Research Funding - Resilience Care (Inst)
Travel, Accommodations, Expenses - Novartis; Novartis
 
Antonio Di Meglio
Expert Testimony - Kephren; techspert.io